A new urine test could help curtail the use of the latest synthetic cannabinoids to enter the drug scene
Low awareness of kidney disease remains a challenge for clinical trial recruitment
30 September 2022Human Brain Project researchers identify new marker of ALS outcome
30 September 2022A new urine test could help curtail the use of the latest synthetic cannabinoids to enter the drug scene
A first-of-its-kind study published today in AACC’s Clinical Chemistry journal shows that a novel drug test detects a new class of synthetic cannabinoids called OXIZIDs. This test could enable drug enforcement agencies to identify OXIZID users and could play a critical role in efforts to stop the spread of these drugs.
